T-piece Versus Pressure-support for the Spontaneous Breathing Trial
- Conditions
- Weaning From Mechanical VentilationExtubation
- Interventions
- Procedure: Pressure-support trialProcedure: T-piece trial
- Registration Number
- NCT04227639
- Lead Sponsor
- Poitiers University Hospital
- Brief Summary
The main objective will be to compare the number of ventilator-free days within the 28 days following the first spontaneous breathing trial between strategies of extubation performing spontaneous breathing trials with T-piece trials or with Pressure-Support trials.
To do that, the study director proposed to conduct a prospective multicenter randomized controlled open-label trial comparing these 2 strategies of weaning in patients at high-risk of extubation failure in the Intensive Care Unit.
Patients included will be randomized before performing the first spontaneous breathing trial and will be assigned to one of the following two groups according to the weaning strategy: T-piece trial group or Pressure-Support trial group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1000
-
Duration of mechanical ventilation prior to the first spontaneous brathing trial > 24h
-
Patients at high-risk of reintubation according to the following criteria: Patients older than 65 years, or those having any underlying chronic cardiac or lung disease.
-
Patient meeting all weaning criteria according to the international conference consensus on weaning.
- Respiratory rate ≤ 35 breaths per minute,
- Adequate oxygenation defined as SpO2 > 90% with FiO2 ≤ 0.4 or PaO2/FiO2 > 150 mm Hg with positive end-expiratory pressure (PEEP) ≤ 8 cmH2O,
- Adequate cough,
- Patient awake with a Richmond Agitation-Sedation Scale between +1 and -2
- No continuous sedation,
- Hemodynamic stability with no need for vasopressors (or minimal dosis).
-
Informed consent given by the relatives or the patient himself.
- Patients admitted for traumatic brain injury
- Pre-existing peripheral neuromuscular disease (underlying myopathy or myasthenia gravis)
- Do-not-reintubate order at time of the first spontaneous breathing trial
- Patient previously included in the study
- No Health insurance coverage
- People under protection: Pregnant or breastfeeding women, minor patients, subjects with guardianship or under law protection.
- Refusal to participate
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pressure-Support trial Pressure-support trial In patients assigned to experimental group all spontaneous breathing trials will be performed with a pressure-support level of 8 cm H2O without positive end-expiratory pressure. T-piece trial T-piece trial In patients assigned to control group all spontaneous breathing trials will be performed using T-piece trial.
- Primary Outcome Measures
Name Time Method Number of ventilator-free days at day 28 Day 28 The number of ventilator-free days at day 28, defined as the number of days alive and without invasive mechanical ventilation (intubation or tracheostomy) between the first spontaneous breathing trial (day 1) and day 28.
- Secondary Outcome Measures
Name Time Method The number of days between the first spontaneous breathing trial and the first extubation attempt among extubated patients Day 28 The number of days alive and without mechanical ventilation (including intubation or non-invasive ventilation) between the first spontaneous breathing trial (day 1) and day 28. Between Day 1 and Day 28 The number of patients extubated within the 72 hours and within the 7 days following the first spontaneous breathing trial. Hour 72, Day 7 The number of patients extubated after simple (24h), difficult (> 24 hours and ≤ 7 days) or prolonged ( > 7 days) weaning Day 28 The number of patients extubated after the first spontaneous breathing trial and not reintubated within the following 72 hours. Hour 72 Numbers of patients died in ICU, at day 28 and at day 90. Day 28 and Day 90 The number of patients reintubated within the 72 hours and within the 7 days following extubation. Day 28 The number of patients with post-extubation respiratory failure within the 7 days following extubation. Day 28 Length of stay in ICU in days. Day 90
Trial Locations
- Locations (1)
Intensive reanimation
🇫🇷Poitiers, France